Evidence map›Paper›PMID 26490104›Full record

ArticleJournal of medical genetics2016

MKS1 regulates ciliary INPP5E levels in Joubert syndrome.

Gisela G Slaats, Christine R Isabella, Hester Y Kroes, Jennifer C Dempsey, Hendrik Gremmels, Glen R Monroe, Ian G Phelps, Karen J Duran, Jonathan Adkins, Sairam A Kumar and 17 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Regulation of INPP5E in Ciliogenesis, Development, and Disease.International journal of biological sciences · 2025
    Review
  3. Technologies, strategies, and cautions when deconvoluting genome-wide association signals: FTO in focus.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2023
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Genotype-phenotype correlates in Joubert syndrome: A review.American journal of medical genetics. Part C, Seminars in medical genetics · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Signaling in the primary cilium through the lens of the Hedgehog pathway.Wiley interdisciplinary reviews. Developmental biology · 2020
    Review
  16. Article
  17. Article
  18. Review
  19. Novel Compound Heterozygous Variants inFrontiers in genetics · 2020
    Article
  20. The Enigmatic Role of Lipids in Cilia Signaling.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 13 institutions in 8 countries.

Gisela G SlaatsDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
Christine R IsabellaDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
Hester Y KroesDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Jennifer C DempseyDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
Hendrik GremmelsDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
Glen R MonroeDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Ian G PhelpsDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
Karen J DuranDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Jonathan AdkinsDepartment of Pediatrics, University of Washington, Seattle, Washington, USA Division of Integrated Cancer Genomics, Translational Genomics Research Institute, Phoenix, Arizona, USA.
Sairam A KumarDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
Dana M KnutzenDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
Nine V KnoersDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Nancy J MendelsohnDepartment of Medical Genetics, Children's Hospitals & Clinics of Minnesota, Minneapolis, Minnesota, USA.
David NeubauerDepartment of Child, Adolescent and Developmental Neurology, University Children's Hospital Ljubljana, Ljubljana, Slovenia.
Sotiria D MastroyianniDepartment of Neurology, Children's Hospital of Athens "P. and A. Kyriakou", Athens, Greece.
Julie VogtWest Midlands Regional Genetics Service, Birmingham Women's Hospital, Birmingham, UK.
Lisa WorganDepartment of Clinical Genetics, Liverpool Hospital, Liverpool, Australia.
Natalya KarpMedical Genetics Program, Department of Pediatrics, London Health Science Centre, University of Western Ontario, London, Ontario, Canada.
Sarah BowdinDivision of Clinical and Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Ian A GlassDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
Melissa A ParisiEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Edgar A OttoDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA.
Colin A JohnsonSection of Ophthalmology and Neuroscience, Leeds Institutes of Molecular Medicine, University of Leeds, Leeds, UK.
Friedhelm HildebrandtDivision of Nephrology, Boston Children's Hospital, Boston, Massachusetts, USA Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
Gijs van HaaftenDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Rachel H GilesDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
Dan DohertyDepartment of Pediatrics, University of Washington, Seattle, Washington, USA Seattle Children's Research Institute, Seattle, Washington, USA.
University Medical Center Utrecht · NLUniversity of Washington · USBirmingham Women's Hospital · GBChildren's Minnesota · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USHospital for Sick Children · CAHoward Hughes Medical Institute · USLiverpool Hospital · AULjubljana University Medical Centre · SIPanagiotis & Aglaia Kyriakou Children's Hospital · GRUniversity of Leeds · GBUniversity of Michigan–Ann Arbor · USWestern University · CA

Funding

Restoring FMRP Phenotypes Frpm Temporal Regional and Splice- Isoforms VarationsP30HD002274 · NICHD · UNIVERSITY OF WASHINGTON · PI LA SPADA, ALBERT R · 1985 to 2013
$33.6M
NCCIH Supplement to NCATS/CTSA Program for KL2 Scholars - M. SoddersKL2TR002317 · NCATS · UNIVERSITY OF WASHINGTON · PI Christy Michelle McKinney · 2017 to 2026
$14.5M
Institute for Translational Health Science (KL2)KL2RR025015 · NCRR · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2007 to 2011
$9.3M
Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 2014 to 2019
$7.9M
Novel genetics, pathobiology & therapy of nephronophthisis-related ciliopathiesR01DK068306 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HILDEBRANDT, FRIEDHELM · 2004 to 2022
$6.6M
Joubert syndrome and related disorders of hindbrain developmentR01NS064077 · NINDS · UNIVERSITY OF WASHINGTON · PI DOHERTY, DANIEL · 2010 to 2014
$1.8M
Identifying all Meckel-like ciliopathy genes by established total exome capture aRC4DK090917 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OTTO, EDGAR A · 2010 to 2010
$1.2M
Molecular basis of Joubert syndrome and related diseasesK23NS045832 · NINDS · UNIVERSITY OF WASHINGTON · PI PARISI, MELISSA ANN · 2003 to 2007
$831k
Genetic analyses of cerebellar malformationsK24HD046712 · NICHD · UNIVERSITY OF WASHINGTON · PI GLASS, IAN AMOS · 2005 to 2009
$492k
Howard Hughes Medical InstituteMedical Research Council MR/K011154/1NCATS NIH HHS KL2 TR002317NCRR NIH HHS KL2 RR025015NCRR NIH HHS KL2-RR025015NICHD NIH HHS K24 HD046712NICHD NIH HHS K24HD046712NICHD NIH HHS P30 HD002274NICHD NIH HHS P30HD002274NICHD NIH HHS U54 HD083091NIDDK NIH HHS DK068306NIDDK NIH HHS DK090917NIDDK NIH HHS R01 DK068306NIDDK NIH HHS RC4 DK090917NIDDK NIH HHS RC4-DK090917NINDS NIH HHS K23 NS045832NINDS NIH HHS K23NS45832NINDS NIH HHS R01 NS064077NINDS NIH HHS R01NS064077
6 · The paper itself

Abstract

backgroundJoubert syndrome (JS) is a recessive ciliopathy characterised by a distinctive brain malformation 'the molar tooth sign'. Mutations in >27 genes cause JS, and mutations in 12 of these genes also cause Meckel-Gruber syndrome (MKS). The goals of this work are to describe the clinical features of MKS1-related JS and determine whether disease causing MKS1 mutations affect cellular phenotypes such as cilium number, length and protein content as potential mechanisms underlying JS.

methodsWe measured cilium number, length and protein content (ARL13B and INPP5E) by immunofluorescence in fibroblasts from individuals with MKS1-related JS and in a three-dimensional (3D) spheroid rescue assay to test the effects of disease-related MKS1 mutations.

resultsWe report MKS1 mutations (eight of them previously unreported) in nine individuals with JS. A minority of the individuals with MKS1-related JS have MKS features. In contrast to the truncating mutations associated with MKS, all of the individuals with MKS1-related JS carry ≥ 1 non-truncating mutation. Fibroblasts from individuals with MKS1-related JS make normal or fewer cilia than control fibroblasts, their cilia are more variable in length than controls, and show decreased ciliary ARL13B and INPP5E. Additionally, MKS1 mutant alleles have similar effects in 3D spheroids.

conclusionsMKS1 functions in the transition zone at the base of the cilium to regulate ciliary INPP5E content, through an ARL13B-dependent mechanism. Mutations in INPP5E also cause JS, so our findings in patient fibroblasts support the notion that loss of INPP5E function, due to either mutation or mislocalisation, is a key mechanism underlying JS, downstream of MKS1 and ARL13B.

Indexed as

Abnormalities, MultipleADP-Ribosylation FactorsAnimalsBrainCells, CulturedCerebellumCiliaExonsEye AbnormalitiesFibroblastsGene Expression RegulationHumansKidney Diseases, CysticMagnetic Resonance ImagingMiceModels, BiologicalADP-Ribosylation FactorsARL13B protein, humanMKS1 protein, humanPhosphoinositide 5-PhosphatasesPhosphoric Monoester HydrolasesProteinsCell biologyGenetics

Identifiers

PMID26490104
PMCPMC5060087
OpenAlexW1834063458

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.